SFN and lung adenocarcinoma: Since alteration of SFN is observed in most lung adenocarcinomas, even AIS and minimally invasive adenocarcinoma, targeted therapy to block SFN might be a new treatment strategy for patients with early-stage lung adenocarcinoma.